Related Experiment Videos
[Effects of leflunomide combined with hormone therapy for refractory IgA nephropathy]
1Department of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. flying1209@ 163.com
Objective:
To investigate the effects and safety of leflunomide combined with hormone therapy for refractory IgA nephropathy.
Methods:
Thirteen patients with refractory IgA nephropathy were treated with leflunomide and hormone therapy, and the clinical data were collected and evaluated before and in weeks 2, 4, 8, 12, 16, 20 and 24 during the treatment.
Results:
Leflunomide therapy significantly improved proteinuria (Plt;0.001) and increased serum albumin in these patients (Plt;0.001) but caused no significant changes in serum creatinine (Pgt;0.05). Only mild tolerable adverse effects were observed.
Conclusion:
Leflunomide combined with hormone therapy can be one of the safety and effective choices for treatment of refractory IgA nephropathy.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Nephrotic Syndrome II : Assessment and Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...